Vaniqa cream is a prescription product used to reduce facial hair in females ages 12 and older. Vaniqa is a topical product that is applied to the skin based on the directions from your doctor. Vaniqa works by preventing cell growth, which stops the growth of facial hair. This product may take several months to start working. Continue taking it exactly as prescribed. Once discontinued, the effects of Vaniqa are reversible. Fact Table Formula C6H12F2N2O2 License EU EMA, US FDA Bioavailability 100% Legal status Rx Only Chemical Name Eflornithine Elimination half-life 8 hours Dosage (Strength) 11.5% Pregnancy Consult Doctor Brands Vaniqa Protein binding - PubChem CID 3009 MedlinePlus a604031 ChEBI 41948 ATC code D11AX16 DrugBank DB06243 KEGG D07883 Routes of administration intravenous, topical

Vaniqa (Eflornithine)

Apply Vaniqa cream to the affected area twice daily, at least eight hours apart. Do not use Vaniqa at the same time as other prescription or cosmetic products. Separate the application of Vaniqa and other products by at least 10-15 minutes. Vaniqa does not cause hair removal. It may take up to 4-8 weeks of treatment before results are seen.
Some of the more common side effects of Vaniqa may include the following: Acne rosacea, Acne vulgaris, Alopecia, Anorexia, Burning sensation of skin, Cheilitis, Contact dermatitis, Dermal hemorrhage, Dizziness, Dyspepsia, Erythema, Facial edema, Folliculitis, Headache, Herpes simplex infection, Ingrown hair, Nausea, Numbness, Pruritus, Pseudofolliculitis barbae, Skin irritation, Skin rash, Stinging of the skin, Swelling of lips, Tingling of the skin, Vertigo, Weakness, Xeroderma Contact your doctor or pharmacist if you experience any of the above side effects. Vaniqa [package insert]. Buffalo, NY: Bristol-Myers Squibb; 2000.

Vaniqa (Eflornithine)

Directions

Ingredients

Cautions

Side Effects